Literature DB >> 1560360

The relaxant properties in guinea pig airways of S-nitrosothiols.

A Jansen1, J Drazen, J A Osborne, R Brown, J Loscalzo, J S Stamler.   

Abstract

Several cellular constituents of the lung have the capacity to synthesize a factor capable of relaxing smooth muscle which has the physicochemical properties of nitric oxide (NO). In other systems, it has been shown that NO may be stabilized in the plasma and cellular milieu by reduced thiol in the form of an S-nitrosothiol (RS-NO). These compounds have half-lives that are significantly greater than that of NO, and also retain the vasorelaxant activity of NO, which is mediated by activating guanylate cyclase and raising cyclic GMP levels. The effects of RS-NO and their potential mechanism of action on airways, however, have not been previously investigated. In this study, we have examined the smooth muscle relaxant properties of several biological and synthetic RS-NO on guinea pig trachea. Our data reveal that RS-NO are generally potent airway smooth muscle relaxants with at least a partial effect through stimulation of cyclic GMP. Relaxations were attenuated significantly by the guanylate cyclase inhibitor methylene blue (P less than .05), and RS-NO-induced increases in cyclic GMP were demonstrated (P less than .0005). The IC50 values for S-nitroso-glutathione, S-nitroso-cysteine, S-nitroso-homocysteine, S-nitroso-N-acetylcysteine, S-nitroso-penicillamine and S-nitroso-captopril were 0.99 +/- 0.09, 3.2 +/- 0.2, 2.1 +/- 0.3, 2.1 +/- 0.8, 1.8 +/- 0.8 and 20 +/- 0.7 microM (mean +/- S.E.M.), respectively. In this system isoproterenol has an IC50 of 0.016 microM and theophylline an IC50 of 74 microM, making the relaxant properties of these NO derivatives of potential pharmacological and physiological relevance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560360

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

Review 1.  Airway smooth muscle relaxation.

Authors:  A J Knox; A E Tattersfield
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

Review 2.  Nitric oxide and lung disease.

Authors:  P J Barnes; M G Belvisi
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

3.  Hydroxyurea enhances SMN2 gene expression through nitric oxide release.

Authors:  Cheng Xu; Xin Chen; Susanna M Grzeschik; Madhuri Ganta; Ching H Wang
Journal:  Neurogenetics       Date:  2010-12-22       Impact factor: 2.660

4.  Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs.

Authors:  J Boer; M Duyvendak; F E Schuurman; F M Pouw; J Zaagsma; H Meurs
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

5.  Nitric oxide counters the inhibitory effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation.

Authors:  Sourabh Kharait; Daniel J Haddad; Matthew L Springer
Journal:  Biochem Biophys Res Commun       Date:  2011-05-20       Impact factor: 3.575

6.  Influence of S-nitrosothiols and nitrate tolerance in the rat gastric fundus.

Authors:  A J Barbier; R A Lefebvre
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Specific mediator inhibition by the NO donors SNP and NCX 2057 in the peripheral lung: implications for allergen-induced bronchoconstriction.

Authors:  Anna-Karin Larsson; Magnus Bäck; Jon O Lundberg; Sven-Erik Dahlén
Journal:  Respir Res       Date:  2009-06-04

Review 8.  The emerging multifaceted roles of nitric oxide.

Authors:  P C Kuo; R A Schroeder
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

9.  An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus.

Authors:  A Gibson; R Babbedge; S R Brave; S L Hart; A J Hobbs; J F Tucker; P Wallace; P K Moore
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 10.  Multiple roles of nitric oxide in the airways.

Authors:  F L M Ricciardolo
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.